Try our beta test site
1 study found for:    lymphoma OR CLL | Procaspase Activating Compound-1
Show Display Options
Rank Status Study
1 Recruiting Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies
Conditions: Breast Cancer;   Lymphoma;   Gastrointestinal Cancers;   Genitourinary Cancers;   Gynecologic Cancers;   Head and Neck Cancers;   Melanoma;   Thoracic Cancers;   Solid Tumors;   Lymphomas
Intervention: Drug: PAC-1

Study has passed its completion date and status has not been verified in more than two years.